Deciphera Pharmaceuticals (DCPH) Tops Q3 EPS by 3c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($0.58), $0.03 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $43.31 million versus the consensus estimate of $39.44 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Benchmark Reiterates Buy Rating on Penske Automotive Group (PAG)
• What Delta’s report tells investors in American and United